1. Home
  2. COFS vs ALLO Comparison

COFS vs ALLO Comparison

Compare COFS & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COFS
  • ALLO
  • Stock Information
  • Founded
  • COFS 1898
  • ALLO 2017
  • Country
  • COFS United States
  • ALLO United States
  • Employees
  • COFS N/A
  • ALLO N/A
  • Industry
  • COFS Major Banks
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • COFS Finance
  • ALLO Health Care
  • Exchange
  • COFS Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • COFS 425.1M
  • ALLO 371.8M
  • IPO Year
  • COFS N/A
  • ALLO 2018
  • Fundamental
  • Price
  • COFS $29.44
  • ALLO $1.34
  • Analyst Decision
  • COFS Strong Buy
  • ALLO Strong Buy
  • Analyst Count
  • COFS 2
  • ALLO 9
  • Target Price
  • COFS $39.00
  • ALLO $8.44
  • AVG Volume (30 Days)
  • COFS 65.8K
  • ALLO 4.1M
  • Earning Date
  • COFS 07-24-2025
  • ALLO 05-13-2025
  • Dividend Yield
  • COFS 3.77%
  • ALLO N/A
  • EPS Growth
  • COFS N/A
  • ALLO N/A
  • EPS
  • COFS 0.80
  • ALLO N/A
  • Revenue
  • COFS $88,657,000.00
  • ALLO N/A
  • Revenue This Year
  • COFS $76.63
  • ALLO N/A
  • Revenue Next Year
  • COFS $10.50
  • ALLO $10.02
  • P/E Ratio
  • COFS $36.99
  • ALLO N/A
  • Revenue Growth
  • COFS 10.12
  • ALLO N/A
  • 52 Week Low
  • COFS $24.01
  • ALLO $0.86
  • 52 Week High
  • COFS $38.15
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • COFS 54.36
  • ALLO 49.26
  • Support Level
  • COFS $29.36
  • ALLO $1.10
  • Resistance Level
  • COFS $30.74
  • ALLO $1.15
  • Average True Range (ATR)
  • COFS 0.48
  • ALLO 0.11
  • MACD
  • COFS -0.10
  • ALLO 0.02
  • Stochastic Oscillator
  • COFS 22.15
  • ALLO 93.75

About COFS ChoiceOne Financial Services Inc.

ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: